NovoCure Ltd
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $655.4 | $605.2 | $509.3 | $537.8 | $535.0 |
| Operating income | -$153.8 | -$170.5 | -$232.9 | -$89.5 | -$44.3 |
| Net income | -$136.2 | -$168.6 | -$207.0 | -$92.5 | -$58.4 |
| Cash Flow Statement | |||||
| Free cash flow | -$75.7 | -$69.2 | -$100.4 | $9.4 | $58.6 |
Shares outstanding 116.4M · Free float 63.4%
Annual filing data through FY ended December 31, 2025; float as of September 11, 2026.